accountAnother S&P 500 constituent, King Pharmaceuticals (KG), is being removed as well. But it's not because of obsolescence. King is getting acquired by drug giant Pfizer (PFE, Fortune 500). But what's really interesting...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to S&P 500 gets makeover
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account